Cargando…

Assessing quality of life in a randomized clinical trial: Correcting for missing data

BACKGROUND: Health-related quality of life is a topic of current interest. This paper considers a randomized phase III study of radiation therapy with concurrent chemotherapy (docetaxel) versus radiation therapy alone in non-small cell lung cancer, stage III A/B. Longitudinal data on quality of life...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunnes, Nina, Seierstad, Taral G, Aamdal, Steinar, Brunsvig, Paal F, Jacobsen, Anne-Birgitte, Sundstrøm, Stein, Aalen, Odd O
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698910/
https://www.ncbi.nlm.nih.gov/pubmed/19405936
http://dx.doi.org/10.1186/1471-2288-9-28
_version_ 1782168436159283200
author Gunnes, Nina
Seierstad, Taral G
Aamdal, Steinar
Brunsvig, Paal F
Jacobsen, Anne-Birgitte
Sundstrøm, Stein
Aalen, Odd O
author_facet Gunnes, Nina
Seierstad, Taral G
Aamdal, Steinar
Brunsvig, Paal F
Jacobsen, Anne-Birgitte
Sundstrøm, Stein
Aalen, Odd O
author_sort Gunnes, Nina
collection PubMed
description BACKGROUND: Health-related quality of life is a topic of current interest. This paper considers a randomized phase III study of radiation therapy with concurrent chemotherapy (docetaxel) versus radiation therapy alone in non-small cell lung cancer, stage III A/B. Longitudinal data on quality of life have been obtained through repeated administration of a multi-item questionnaire (EORTC QLQ-C30) developed by the European Organisation for Research and Treatment of Cancer. Missingness in the data is owing to patients having failed to complete the questionnaire at some of the scheduled filling-in times. METHODS: We have analysed a monotone (in terms of missingness) subset of the data as regards estimation of the mean score of a summary measure of self-reported quality of life in a hypothetical drop-out-free population at different points in time. Missingness is a difficult issue of great importance. We have therefore chosen to compare three different methods that are relatively easy to implement: the linear-increments method, the inverse-probability-weighting method and the Markov-process method. Single imputation has been applied in a supplementary analysis to fill in for all the non-consecutive missing score values prior to the execution of the estimation procedure. RESULTS: For the response in focus, the observed mean score at a certain time is larger than the estimated mean scores, which implies that the true mean score is easily overestimated unless the missingness is appropriately adjusted for. Comparison of the treatment arms shows a significant difference in mean score at the end of treatment. CONCLUSION: Use of proper methodology developed for analysing data subject to missingness is necessary to reduce potential estimation bias. The quality of life of patients receiving radiation therapy with concurrent chemotherapy (docetaxel) appears somewhat worse than that of patients receiving radiation therapy alone in the period during which treatment is given. The conclusions are robust for the choice of statistical methods.
format Text
id pubmed-2698910
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26989102009-06-19 Assessing quality of life in a randomized clinical trial: Correcting for missing data Gunnes, Nina Seierstad, Taral G Aamdal, Steinar Brunsvig, Paal F Jacobsen, Anne-Birgitte Sundstrøm, Stein Aalen, Odd O BMC Med Res Methodol Research Article BACKGROUND: Health-related quality of life is a topic of current interest. This paper considers a randomized phase III study of radiation therapy with concurrent chemotherapy (docetaxel) versus radiation therapy alone in non-small cell lung cancer, stage III A/B. Longitudinal data on quality of life have been obtained through repeated administration of a multi-item questionnaire (EORTC QLQ-C30) developed by the European Organisation for Research and Treatment of Cancer. Missingness in the data is owing to patients having failed to complete the questionnaire at some of the scheduled filling-in times. METHODS: We have analysed a monotone (in terms of missingness) subset of the data as regards estimation of the mean score of a summary measure of self-reported quality of life in a hypothetical drop-out-free population at different points in time. Missingness is a difficult issue of great importance. We have therefore chosen to compare three different methods that are relatively easy to implement: the linear-increments method, the inverse-probability-weighting method and the Markov-process method. Single imputation has been applied in a supplementary analysis to fill in for all the non-consecutive missing score values prior to the execution of the estimation procedure. RESULTS: For the response in focus, the observed mean score at a certain time is larger than the estimated mean scores, which implies that the true mean score is easily overestimated unless the missingness is appropriately adjusted for. Comparison of the treatment arms shows a significant difference in mean score at the end of treatment. CONCLUSION: Use of proper methodology developed for analysing data subject to missingness is necessary to reduce potential estimation bias. The quality of life of patients receiving radiation therapy with concurrent chemotherapy (docetaxel) appears somewhat worse than that of patients receiving radiation therapy alone in the period during which treatment is given. The conclusions are robust for the choice of statistical methods. BioMed Central 2009-04-30 /pmc/articles/PMC2698910/ /pubmed/19405936 http://dx.doi.org/10.1186/1471-2288-9-28 Text en Copyright ©2009 Gunnes et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gunnes, Nina
Seierstad, Taral G
Aamdal, Steinar
Brunsvig, Paal F
Jacobsen, Anne-Birgitte
Sundstrøm, Stein
Aalen, Odd O
Assessing quality of life in a randomized clinical trial: Correcting for missing data
title Assessing quality of life in a randomized clinical trial: Correcting for missing data
title_full Assessing quality of life in a randomized clinical trial: Correcting for missing data
title_fullStr Assessing quality of life in a randomized clinical trial: Correcting for missing data
title_full_unstemmed Assessing quality of life in a randomized clinical trial: Correcting for missing data
title_short Assessing quality of life in a randomized clinical trial: Correcting for missing data
title_sort assessing quality of life in a randomized clinical trial: correcting for missing data
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698910/
https://www.ncbi.nlm.nih.gov/pubmed/19405936
http://dx.doi.org/10.1186/1471-2288-9-28
work_keys_str_mv AT gunnesnina assessingqualityoflifeinarandomizedclinicaltrialcorrectingformissingdata
AT seierstadtaralg assessingqualityoflifeinarandomizedclinicaltrialcorrectingformissingdata
AT aamdalsteinar assessingqualityoflifeinarandomizedclinicaltrialcorrectingformissingdata
AT brunsvigpaalf assessingqualityoflifeinarandomizedclinicaltrialcorrectingformissingdata
AT jacobsenannebirgitte assessingqualityoflifeinarandomizedclinicaltrialcorrectingformissingdata
AT sundstrømstein assessingqualityoflifeinarandomizedclinicaltrialcorrectingformissingdata
AT aalenoddo assessingqualityoflifeinarandomizedclinicaltrialcorrectingformissingdata